Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rusfertide in Chinese Patients With Polycythemia Vera
NCT07765602Phase 2Not yet recruiting
- Sponsor
- Takeda
- Start
- Mar 2027
- Primary completion
- Jul 2028
01
Overview
A Phase 2 trial of rusfertide in polycythemia vera (PV), sponsored by Takeda. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
rusfertide
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT07765602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07765602.